Stomach Neoplasms: all 2,914 studies
Page 2 of 30. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric CancerRecruitingNCT07615374Not applicable
- PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric CancerRecruitingNCT07607119Not applicable
- AI-Based Risk Prediction Model for Upper Digestive Tract CancerNot yet recruitingNCT07605312
- Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07603349Phase 2/3
- Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract CancersRecruitingNCT07600125
- Statewide Unified Network for Remote Intervention of Strength and ExerciseNot yet recruitingNCT07596732Not applicable
- Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair DeficiencyNot yet recruitingNCT07595523Phase 2
- To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsRecruitingNCT07594964Phase 1
- A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.RecruitingNCT07593820Phase 1
- Alternative Splicing Based Prediction of Chemotherapy Response in Gastric CancerRecruitingNCT07587229
- Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled TrialRecruitingNCT07586384Not applicable
- A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver MetastasesNot yet recruitingNCT07581730
- GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerNot yet recruitingNCT07581405Phase 2
- A Phase 1 Study of IM-1617 in Participants With Advanced CancerRecruitingNCT07578571Phase 1
- Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNANot yet recruitingNCT07574957
- Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal CancerNot yet recruitingNCT07565857Not applicable
- Exercise Training After Upper Gastrointestinal Cancer SurgeryRecruitingNCT07561840Not applicable
- Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled TrialNot yet recruitingNCT07561073Not applicable
- LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory StudyRecruitingNCT07556640Phase 2
- Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET ImagingNot yet recruitingNCT07554742
- Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric CancerRecruitingNCT07552402Not applicable
- AI Model for Early Gastric Cancer Diagnosis Using Endoscopic ImagingRecruitingNCT07551466
- Identification of Therapeutic Targets in Metastatic Gastric CancerRecruitingNCT07551440
- Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ CancerRecruitingNCT07551362Phase 1/2
- A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)RecruitingNCT07547787
- Association Between Microplastic Exposure and the Pathological Progression of Gastric CarcinogenesisRecruitingNCT07542652
- Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR CancersEnrolling by invitationNCT07542262Phase 2
- Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled TrialRecruitingNCT07540026Not applicable
- Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric CancerRecruitingNCT07537361Phase 2
- Laparoscopic Staging for Stage III Gastric CancerEnrolling by invitationNCT07533825Not applicable
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaRecruitingNCT07529808Phase 1/2
- AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric CancerRecruitingNCT07525765
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsRecruitingNCT07523529Phase 1/2
- A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line TreatmentRecruitingNCT07518147Phase 3
- The UGIRA International Registry for RAMIG for Gastric CancerRecruitingNCT07517432
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
- Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric CancerRecruitingNCT07517107Phase 2
- Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07515625Phase 2
- Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric CancerNot yet recruitingNCT07511894Phase 2
- 18F-FAPI PET/CT and MRI in Gastric CancerNot yet recruitingNCT07510867
- Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The PeritoneumRecruitingNCT07509008Phase 1/2
- Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07507916Phase 2
- Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal LesionsNot yet recruitingNCT07507071
- Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41RecruitingNCT07504913
- Large Language Models Assist in Tumor MDTRecruitingNCT07504367Not applicable
- A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07502027Phase 4
- A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT07492615Phase 2
- PROGAIN Trial in Gastric Cancer SurgeryRecruitingNCT07488611Phase 3
- Safety and Efficacy of Leucine-Restricted Diet in Gastric CancerEnrolling by invitationNCT07488312Phase 1
- A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In IndiaRecruitingNCT07486518
- Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction CancerRecruitingNCT07482566Not applicable
- A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal AdenocarcinomaRecruitingNCT07481357Phase 1
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in AlgeriaRecruitingNCT07481110
- RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal GastrectomyNot yet recruitingNCT07467174Phase 4
- Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal CancersRecruitingNCT07464470
- QLS5132 Combination Therapy in Advanced Solid TumorsNot yet recruitingNCT07453394Phase 1/2
- Comparison of the Postoperative Analgesic Effects of the Temperature-responsive Gel Mixed With Local Anesthetics Application and Ultrasound-guided Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic GastrectomyNot yet recruitingNCT07452471Not applicable
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionNot yet recruitingNCT07446049Phase 2
- Early Postoperative Intervention in Gastric Cancer PatientsEnrolling by invitationNCT07444099Not applicable
- Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant TherapyRecruitingNCT07441850Not applicable
- Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction CancerRecruitingNCT07441785
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07432633Phase 1/2
- Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)RecruitingNCT07432295Phase 2
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2RecruitingNCT07431281Phase 3
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer PatientsRecruitingNCT07405931Not applicable
- Full-time RDI for ESD: Impact on Major Adverse Events and Procedure TimeRecruitingNCT07401303Not applicable
- Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)RecruitingNCT07401199
- DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)RecruitingNCT07401173
- The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut MicrobiotaRecruitingNCT07400354
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerRecruitingNCT07392892Phase 2/3
- Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOXNot yet recruitingNCT07391826Phase 2
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.RecruitingNCT07390838Phase 1
- Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ AdenocarcinomaRecruitingNCT07389876
- A Clinical Study of GK02 in Malignant AscitesRecruitingNCT07378436Early Phase 1
- Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric CancerRecruitingNCT07374731
- Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ AdenocarcinomaNot yet recruitingNCT07374250Phase 2
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2
- Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric CancerRecruitingNCT07366528Phase 3
- MRinRT: Swansea University and SWWCC Collaboration Study.Not yet recruitingNCT07365124
- To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerNot yet recruitingNCT07364422Phase 1/2
- Prolonged Extubation in Gastric Cancer With OSAEnrolling by invitationNCT07362706
- Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsRecruitingNCT07360314Phase 1
- Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaRecruitingNCT07359586
- First in Human Study of QLS5316 in Solid TumorsNot yet recruitingNCT07358884Phase 1
- Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction AdenocarcinomaEnrolling by invitationNCT07356466Early Phase 1
- A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid TumorsRecruitingNCT07354711Phase 1/2
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerRecruitingNCT07334431Phase 1/2
- Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201Not yet recruitingNCT07333820Phase 1
- A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric CancerNot yet recruitingNCT07333573Phase 1/2
- The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related DiseasesNot yet recruitingNCT07332104
- Robotic vs Laparoscopic Gastrectomy for cT4a Gastric CancerNot yet recruitingNCT07331454Phase 3
- Evaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer ScreeningNot yet recruitingNCT07323186Not applicable
- Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerRecruitingNCT07320586Phase 2
- A Phase 1 Study of JMT108 in Participants With Advanced Solid TumorsRecruitingNCT07317505Phase 1
- Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction CancerRecruitingNCT07315854Phase 2
- A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT07315750Phase 3
- QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric CancerNot yet recruitingNCT07315035Phase 2